259 related articles for article (PubMed ID: 16556132)
41. [The multiple organ failure syndrome (MOFS) and septic states].
Litarczek G
Chirurgia (Bucur); 1991; 40(2):141-54. PubMed ID: 1688107
[TBL] [Abstract][Full Text] [Related]
42. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial.
Payen D; Mateo J; Cavaillon JM; Fraisse F; Floriot C; Vicaut E;
Crit Care Med; 2009 Mar; 37(3):803-10. PubMed ID: 19237881
[TBL] [Abstract][Full Text] [Related]
43. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis.
Sharma R; Tepas JJ; Hudak ML; Mollitt DL; Wludyka PS; Teng RJ; Premachandra BR
J Pediatr Surg; 2007 Mar; 42(3):454-61. PubMed ID: 17336180
[TBL] [Abstract][Full Text] [Related]
44. Multiple organ dysfunction syndrome in the trauma patient.
Aragon D; Parson R
Crit Care Nurs Clin North Am; 1994 Dec; 6(4):873-81. PubMed ID: 7766360
[TBL] [Abstract][Full Text] [Related]
45. Organ dysfunction in patients with severe sepsis.
Vincent JL
Surg Infect (Larchmt); 2006; 7 Suppl 2():S69-72. PubMed ID: 16895511
[TBL] [Abstract][Full Text] [Related]
46. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis.
Hirasawa H; Oda S; Nakamura M; Watanabe E; Shiga H; Matsuda K
Blood Purif; 2012; 34(2):164-70. PubMed ID: 23095416
[TBL] [Abstract][Full Text] [Related]
47. [Hybrid technologies of renal replacement therapy in the treatment of multiple organ failure in cardiosurgical patients].
Iarustovskiĭ MB; Nazarova EI
Anesteziol Reanimatol; 2006; (3):67-70. PubMed ID: 16889218
[TBL] [Abstract][Full Text] [Related]
48. Successful management of a critically ill burn patient suffering sepsis by use of endotoxin absorption therapy (PMX).
Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M; Morioka K
Burns; 2004 May; 30(3):276-9. PubMed ID: 15082359
[No Abstract] [Full Text] [Related]
49. [The present strategy and ponderation on prevention and treatment of burn sepsis and multiple organ dysfunction syndrome (MODS)].
Chai JK; Sheng ZY
Zhonghua Shao Shang Za Zhi; 2008 Oct; 24(5):378-80. PubMed ID: 19103024
[TBL] [Abstract][Full Text] [Related]
50. [The role of cell adhesion molecules and proinflammatory mediators in the pathogenesis of endotoxin adult respiratory distress syndrome].
Lazarov S; Balutsov M; Ianev E
Vutr Boles; 2000; 32(4):18-24. PubMed ID: 11688326
[TBL] [Abstract][Full Text] [Related]
51. Role of endotoxin and proteases in multiple organ failure (MOF).
Aasen AO; Rishovd AL; Stadaas JO
Prog Clin Biol Res; 1989; 308():315-22. PubMed ID: 2675056
[No Abstract] [Full Text] [Related]
52. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection.
Shapiro N; Howell MD; Bates DW; Angus DC; Ngo L; Talmor D
Ann Emerg Med; 2006 Nov; 48(5):583-90, 590.e1. PubMed ID: 17052559
[TBL] [Abstract][Full Text] [Related]
53. [High-volume hemodiafiltration in the treatment of sepsis and multiple organ failure: 2 methods of the elimination of TNF-alpha].
Iakovleva II; Timokhov VS; Lialikova GV; Pestriakov EV; Moroz VV; Mura'ev OB; Sergeev AIu
Anesteziol Reanimatol; 2001; (2):46-8. PubMed ID: 11494901
[TBL] [Abstract][Full Text] [Related]
54. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome.
Stegmayr BG
Ther Apher; 2001 Apr; 5(2):123-7. PubMed ID: 11354296
[TBL] [Abstract][Full Text] [Related]
55. Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure.
Matsuda K; Moriguchi T; Harii N; Goto J
Transfus Apher Sci; 2009 Feb; 40(1):49-53. PubMed ID: 19103511
[TBL] [Abstract][Full Text] [Related]
56. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
57. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a.
Schefold JC; von Haehling S; Corsepius M; Pohle C; Kruschke P; Zuckermann H; Volk HD; Reinke P
Shock; 2007 Oct; 28(4):418-25. PubMed ID: 17558345
[TBL] [Abstract][Full Text] [Related]
58. Cytopathic hypoxia. A concept to explain organ dysfunction in sepsis.
Fink MP
Minerva Anestesiol; 2000 May; 66(5):337-42. PubMed ID: 10965712
[TBL] [Abstract][Full Text] [Related]
59. [Efficacy and safety of coupled plasma filtration adsorption combined with continuous veno-venous hemofiltration for multiple organ dysfunction syndrome patients with acute liver failure].
He CS; Shi W; Ye ZM; Liang XL; Zhang B; Liu SX; Qin TH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):47-9. PubMed ID: 17207366
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats.
Wu JY; Tsou MY; Chen TH; Chen SJ; Tsao CM; Wu CC
J Pineal Res; 2008 Aug; 45(1):106-16. PubMed ID: 18298464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
